Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Bero

Showing results (71-80 of 206) with videos related to

Pageof 21
Sort By:
Health Research Policy and Systems|December 7, 2019
Health promoter, advocate, legitimiser - the many roles of WHO guidelines: a qualitative studyZhicheng Wang, Quinn Grundy, Lisa Parker, et al.
BMJ (Clinical Research Ed.)|April 25, 2013
Searching for unpublished data for Cochrane reviews: cross sectional studyJeppe Bennekou Schroll, Lisa Bero, Peter C Gøtzsche
Journal of Clinical Epidemiology|July 19, 2022
Experts identified warning signs of fraudulent research: a qualitative study to inform a screening toolLisa Parker, Stephanie Boughton, Rosa Lawrence, et al.
BMC Public Health|November 24, 2020
Variations in processes for guideline adaptation: a qualitative study of World Health Organization staff experiences in implementing guidelinesZhicheng Wang, Quinn Grundy, Lisa Parker, et al.
BMJ (Clinical Research Ed.)|June 26, 2020
Commercial influence and covid-19Ray Moynihan, Helen Macdonald, Lisa Bero, et al.
Bulletin of the World Health Organization|December 3, 2010
To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008Lisa Bero, Brittany Carson, Helene Moller, et al.
Journal of Clinical Epidemiology|August 24, 2014
The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reportsJeppe Bennekou Schroll, Maher Abdel-Sattar, Lisa Bero
Plos Biology|January 28, 2014
Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysisDavid Krauth, Andrew Anglemyer, Rose Philipps, et al.
Policy, Politics & Nursing Practice|September 7, 2022
Branded Care: The Policy Implications of Pharmaceutical Industry-Funded Nursing Care Related to Specialty MedicinesQuinn Grundy, Larkin Davenport Huyer, Lisa Parker, et al.
Evidence-Based Preclinical Medicine|February 3, 2015
The Relationship between Risk of Bias Criteria, Research Outcomes, and Study Sponsorship in a Cohort of Preclinical Thiazolidinedione Animal Studies: A Meta-AnalysisMaher Abdel-Sattar, David Krauth, Andrew Anglemyer, et al.
Pageof 21

Showing results (71-80 of 206) with videos related to

Sort By:
Pageof 21
Health Research Policy and Systems|December 7, 2019
Health promoter, advocate, legitimiser - the many roles of WHO guidelines: a qualitative studyZhicheng Wang, Quinn Grundy, Lisa Parker, et al.
BMJ (Clinical Research Ed.)|April 25, 2013
Searching for unpublished data for Cochrane reviews: cross sectional studyJeppe Bennekou Schroll, Lisa Bero, Peter C Gøtzsche
Journal of Clinical Epidemiology|July 19, 2022
Experts identified warning signs of fraudulent research: a qualitative study to inform a screening toolLisa Parker, Stephanie Boughton, Rosa Lawrence, et al.
BMC Public Health|November 24, 2020
Variations in processes for guideline adaptation: a qualitative study of World Health Organization staff experiences in implementing guidelinesZhicheng Wang, Quinn Grundy, Lisa Parker, et al.
BMJ (Clinical Research Ed.)|June 26, 2020
Commercial influence and covid-19Ray Moynihan, Helen Macdonald, Lisa Bero, et al.
Bulletin of the World Health Organization|December 3, 2010
To give is better than to receive: compliance with WHO guidelines for drug donations during 2000-2008Lisa Bero, Brittany Carson, Helene Moller, et al.
Journal of Clinical Epidemiology|August 24, 2014
The Food and Drug Administration reports provided more data but were more difficult to use than the European Medicines Agency reportsJeppe Bennekou Schroll, Maher Abdel-Sattar, Lisa Bero
Plos Biology|January 28, 2014
Nonindustry-sponsored preclinical studies on statins yield greater efficacy estimates than industry-sponsored studies: a meta-analysisDavid Krauth, Andrew Anglemyer, Rose Philipps, et al.
Policy, Politics & Nursing Practice|September 7, 2022
Branded Care: The Policy Implications of Pharmaceutical Industry-Funded Nursing Care Related to Specialty MedicinesQuinn Grundy, Larkin Davenport Huyer, Lisa Parker, et al.
Evidence-Based Preclinical Medicine|February 3, 2015
The Relationship between Risk of Bias Criteria, Research Outcomes, and Study Sponsorship in a Cohort of Preclinical Thiazolidinedione Animal Studies: A Meta-AnalysisMaher Abdel-Sattar, David Krauth, Andrew Anglemyer, et al.
Pageof 21